Michelle Hudson

1.9k total citations
20 papers, 707 citations indexed

About

Michelle Hudson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Michelle Hudson has authored 20 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Genetics. Recurrent topics in Michelle Hudson's work include Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (7 papers) and Diabetes Management and Research (6 papers). Michelle Hudson is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (7 papers) and Diabetes Management and Research (6 papers). Michelle Hudson collaborates with scholars based in United Kingdom, United States and Netherlands. Michelle Hudson's co-authors include Ewan R. Pearson, Andrew T. Hattersley, Beverley M. Shields, Timothy J. McDonald, Maggie Shepherd, Sian Ellard, Richard A. Oram, Suzanne Hammersley, Kevin Colclough and Bridget Knight and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Diabetologia.

In The Last Decade

Michelle Hudson

19 papers receiving 697 citations

Peers

Countries citing papers authored by Michelle Hudson

Since Specialization

Citations

This map shows the geographic impact of Michelle Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Hudson more than expected).

Fields of papers citing papers by Michelle Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Hudson. The network helps show where Michelle Hudson may publish in the future.

Co-authorship network of co-authors of Michelle Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Hudson. A scholar is included among the top collaborators of Michelle Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Hudson. Michelle Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes 2022 ·Diabetologia ·Rebecca C. Wyatt, William Hagopian, Bart O. Roep, Kashyap Patel, Brittany Resnick, (unknown), Michelle Hudson, Elisa De Franco, Sian Ellard, Sarah E. Flanagan, Andrew T. Hattersley, Richard A. Oram, Matthew B. Johnson	2
2	The effectiveness of e‐health interventions for the treatment of overweight or obesity in children and adolescents: A systematic review and meta‐analysis 2021 ·Obesity Reviews ·Liane B. Azevedo, John Stephenson, Louisa Ells, (unknown), Ann DeSmet, Emma L. Giles, Anna Haste, Claire O’Malley, Dan Jones, Li Kheng Chai, Tracy Burrows, Clare E. Collins, Amy van Grieken, Michelle Hudson	41
3	Machine Learning based histology phenotyping to investigate the epidemiologic and genetic basis of adipocyte morphology and cardiometabolic traits 2020 ·PLoS Computational Biology ·Craig A. Glastonbury, Sara L. Pulit, (unknown), Jenny C. Censin, Samantha Laber, Hanieh Yaghootkar, Nilüfer Rahmioğlu, (unknown), Katarina Kos, Andrew Pitt, Michelle Hudson, Christoffer Nellåker, Nicola L. Beer, Hans Hauner, Christian M. Becker, Krina T. Zondervan, Timothy M. Frayling, Melina Claussnitzer, Cecilia M. Lindgren	11
4	Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells 2020 ·Diabetologia ·Matthew B. Johnson, Kashyap Patel, Elisa De Franco, William Hagopian, Michael Killian, Timothy J. McDonald, Timothy Tree, Clara Domingo‐Vila, Michelle Hudson, Suzanne Hammersley, (unknown), Sian Ellard, Sarah E. Flanagan, Andrew T. Hattersley, Richard A. Oram	27
5	Strategies to identify individuals with monogenic diabetes: results of an economic evaluation 2020 ·BMJ Open ·Jaime Peters, Rob Anderson, Beverley M. Shields, (unknown), Michelle Hudson, Maggie Shepherd, Timothy J. McDonald, Ewan R. Pearson, Andrew T. Hattersley, Chris Hyde	8
6	Motivations for data sharing—views of research participants from four European countries: A DIRECT study 2019 ·European Journal of Human Genetics ·Nisha Shah, Victoria Coathup, Harriet Teare, Ian Forgie, Giuseppe N. Giordano, Tue H. Hansen, Lenka Groeneveld, Michelle Hudson, Ewan R. Pearson, Hartmut Ruetten, Jane Kaye	25
7	C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase 2018 ·Diabetes Care ·Beverley M. Shields, Timothy J. McDonald, Richard A. Oram, Anita Hill, Michelle Hudson, Pia Leete, Ewan R. Pearson, Sarah J. Richardson, Noel G. Morgan, Andrew T. Hattersley, Bart O. Roep, Timothy Tree, S. Hammersley, (unknown)	75
8	Sharing data for future research'engaging participants' views about data governance beyond the original project: a DIRECT Study 2018 ·Genetics in Medicine ·Nisha Shah, Victoria Coathup, Harriet Teare, Ian Forgie, Giuseppe N. Giordano, Tue H. Hansen, Lenka Groeneveld, Michelle Hudson, Ewan R. Pearson, Hartmut Ruetten, Jane Kaye	32
9	A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin 2018 ·Diabetologia ·(unknown), Maggie Shepherd, Beverley M. Shields, Michelle Hudson, Ewan R. Pearson, Christopher Hyde, Sian Ellard, Andrew T. Hattersley, Kashyap Patel	67
10	Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients 2017 ·Diabetes Care ·Beverley M. Shields, Maggie Shepherd, Michelle Hudson, Timothy J. McDonald, Kevin Colclough, Jaime Peters, Bridget Knight, Chris Hyde, Sian Ellard, Ewan R. Pearson, Andrew T. Hattersley	97
11	Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic 2017 ·Clinical Kidney Journal ·Rhian Clissold, Jonathan Fulford, Michelle Hudson, Beverley M. Shields, Timothy J. McDonald, Sian Ellard, Andrew T. Hattersley, Coralie Bingham	7
12	Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes 2016 ·Diabetes Care ·Maggie Shepherd, Beverley M. Shields, Suzanne Hammersley, Michelle Hudson, Timothy J. McDonald, Kevin Colclough, Richard A. Oram, Bridget Knight, Christopher Hyde, Julian Cox, (unknown), Christopher Moudiotis, Rebecca Smith, Barbara Fraser, Simon Robertson, Stephen Greene, Sian Ellard, Ewan R. Pearson, Andrew T. Hattersley	167
13	Cognitive Improvement After Left Ventricular Assist Device Implant 2015 ·Journal of Cardiac Failure ·Michelle Hudson, (unknown), Thomas A. Schwann, George V. Moukarbel, Samer Khouri, (unknown), Mark R. Bonnell	1
14	A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs 2014 ·Pancreas ·Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, (unknown), Michelle Hudson, (unknown), Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, (unknown), Kjell Öberg	2
15	Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors 2014 ·Diabetes Care ·Richard A. Oram, Timothy J. McDonald, Beverley M. Shields, Michelle Hudson, Maggie Shepherd, Suzanne Hammersley, Ewan R. Pearson, Andrew T. Hattersley, (unknown)	85
16	Phase I dose-escalation study of pasireotide LAR in patients with advanced neuroendocrine tumors. 2013 ·Journal of Clinical Oncology ·Alexandria T. Phan, Edward M. Wolin, Jennifer A. Chan, (unknown), Michelle Hudson, Gareth Hughes, Guoxiang Shen, Jonathan Strosberg	1
17	A multicenter, randomized, blinded, phase III study of pasireotide LAR versus octreotide LAR in patients with metastatic neuroendocrine tumors (NET) with disease-related symptoms inadequately controlled by somatostatin analogs. 2013 ·Journal of Clinical Oncology ·Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, (unknown), Michelle Hudson, (unknown), Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, Wasat Mansoor, Kjell E. Öberg	22
18	Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single‐center, phase I, randomized, four‐way crossover study 2013 ·The Journal of Clinical Pharmacology ·Astrid Breitschaft, Ke Hu, Christelle Darstein, Monica Ligueros‐Saylan, Pierre J. Jordaan, Dongweon Song, Michelle Hudson, Rashmi R. Shah	12
19	An Open-Label Dose-Escalation Study of Once-Daily and Twice-Daily Pasireotide in Healthy Volunteers 2012 ·American Journal of Therapeutics ·Magdy Shenouda, Mario Maldonado, Yanfeng Wang, (unknown), Michelle Hudson, (unknown), Ke Hu	23
20	Automated Fluorometric Analysis of Epinephrine in Lidocaine Hydrochloride Injection 1976 ·Journal of Pharmaceutical Sciences ·Michelle Hudson, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact